Target of the Week - ATG5 Antibodies

|
Dear Cancer Researcher, Abgent offers a portfolio of antibodies for the detection of ATG5 in western blotting, immunohistochemistry and immunofluorescence. Abgent antibodies against ATG5 have been cited in numerous publications demonstrating the role of this autophagy protein in tumorigenesis, melanoma, viral replication, prostate cancer, organogenesis, neural aging, hepatocellular carcinoma, and Alzheimer's. To find the right antibody for your research, and product citations please visit Abgent ATG5 Antibodies. |
Polyclonal ATG5 AntibodyCat# AP1812b |
Polyclonal ATG5 AntibodyCat# AP1802a |
Monoclonal ATG5 AntibodyCat# AM8427b |
Polyclonal ATG5 AntibodyCat# AP1812c |
![]() |
![]() |
![]() |






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.


